Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2

The ongoing vaccination program in the control of novel coronavirus (COVID-19)is providing an opportunity to public health authorities to emerge from the current pandemic crisis.Covid vaccination which protects from getting Covid may have some minor side effects and in rare cases was accompanied by...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Demetris Savva, Gopi Battineni, Francesco Amenta, Giulio Nittari
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	SARS-CoV-2 COVID-19 Vaccination Dermal filler Hyaluronic acid Hypersensitivity response Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/227ba8156c0344c2b9a3fc21b8be73ea
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:227ba8156c0344c2b9a3fc21b8be73ea
record_format	dspace
spelling	oai:doaj.org-article:227ba8156c0344c2b9a3fc21b8be73ea2021-11-12T04:27:14ZHypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-21201-971210.1016/j.ijid.2021.09.066https://doaj.org/article/227ba8156c0344c2b9a3fc21b8be73ea2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1201971221007736https://doaj.org/toc/1201-9712The ongoing vaccination program in the control of novel coronavirus (COVID-19)is providing an opportunity to public health authorities to emerge from the current pandemic crisis.Covid vaccination which protects from getting Covid may have some minor side effects and in rare cases was accompanied by severe or immediate reactions. The development of hyaluronic acid soft tissue filler delayed inflammatory reactions following COVID-19 vaccination was reported. Treatments based on hyaluronic acid represent one of the most largely used practice of aesthetic medicine. In this we present a case of a 38-year-old female patient with a confirmed hypersensitivity reaction after having the BNT162b2 vaccine (Pfizer, USA). This case indicates that an adequate patient knowledge prior to hyaluronic acid injections to avoid adverse effect of a delayed-type hypersensitivity response after COVID-19 vaccination is desirable.Demetris SavvaGopi BattineniFrancesco AmentaGiulio NittariElsevierarticleSARS-CoV-2COVID-19VaccinationDermal fillerHyaluronic acidHypersensitivity responseInfectious and parasitic diseasesRC109-216ENInternational Journal of Infectious Diseases, Vol 113, Iss , Pp 233-235 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	SARS-CoV-2 COVID-19 Vaccination Dermal filler Hyaluronic acid Hypersensitivity response Infectious and parasitic diseases RC109-216
spellingShingle	SARS-CoV-2 COVID-19 Vaccination Dermal filler Hyaluronic acid Hypersensitivity response Infectious and parasitic diseases RC109-216 Demetris Savva Gopi Battineni Francesco Amenta Giulio Nittari Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
description	The ongoing vaccination program in the control of novel coronavirus (COVID-19)is providing an opportunity to public health authorities to emerge from the current pandemic crisis.Covid vaccination which protects from getting Covid may have some minor side effects and in rare cases was accompanied by severe or immediate reactions. The development of hyaluronic acid soft tissue filler delayed inflammatory reactions following COVID-19 vaccination was reported. Treatments based on hyaluronic acid represent one of the most largely used practice of aesthetic medicine. In this we present a case of a 38-year-old female patient with a confirmed hypersensitivity reaction after having the BNT162b2 vaccine (Pfizer, USA). This case indicates that an adequate patient knowledge prior to hyaluronic acid injections to avoid adverse effect of a delayed-type hypersensitivity response after COVID-19 vaccination is desirable.
format	article
author	Demetris Savva Gopi Battineni Francesco Amenta Giulio Nittari
author_facet	Demetris Savva Gopi Battineni Francesco Amenta Giulio Nittari
author_sort	Demetris Savva
title	Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
title_short	Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
title_full	Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
title_fullStr	Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
title_full_unstemmed	Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
title_sort	hypersensitivity reaction to hyaluronic acid dermal filler after the pfizer vaccination against sars-cov-2
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/227ba8156c0344c2b9a3fc21b8be73ea
work_keys_str_mv	AT demetrissavva hypersensitivityreactiontohyaluronicaciddermalfillerafterthepfizervaccinationagainstsarscov2 AT gopibattineni hypersensitivityreactiontohyaluronicaciddermalfillerafterthepfizervaccinationagainstsarscov2 AT francescoamenta hypersensitivityreactiontohyaluronicaciddermalfillerafterthepfizervaccinationagainstsarscov2 AT giulionittari hypersensitivityreactiontohyaluronicaciddermalfillerafterthepfizervaccinationagainstsarscov2
_version_	1718431277374242816

Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2

Ejemplares similares